News
4h
Stocktwits on MSNRetail Bulls Stick With Sarepta After 8-Year-Old Patient’s Death Deemed Unrelated To DMD Gene TherapyRetail sentiment around Sarepta Therapeutics remained upbeat on Monday after the company said Friday that the death of an ...
15h
TipRanks on MSNSarepta says eight-year-old death deemed unrelated to Elevidys"Martir’s absence rippled beyond the school walls, touching the hearts of neighbors and strangers alike, who united in a shared hope for his safe return," Sara Myers, a spokesperson for the Torrance ...
The Trump FDA tries to kill a therapy that has helped boys with a deadly diagnosis.
The FDA is investigating the death last month of an eight-year-old boy in Brazil who had received Sarepta Therapeutics’ Elevidys® (delandistrogene moxeparvovec-rokl)—though the company and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results